Overview

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the study drug is effective and safe in the treatment of Multiple Sclerosis (MS) in patients of Chinese origin.

Phase:

Phase 3

Details

Lead Sponsor:

Bayer

Treatments:

Interferon beta-1b
Interferon-beta
Interferons